We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2024 Volume 4 Issue 2

A Hybrid Fuzzy-ML Clinical Decision Support System for Breast Cancer Risk Stratification: Design, Symbolic/Statistical Risk Fusion, and Proof-of-Concept Validation


, ,
  1. Department of Oncology, School of Medicine, University of Doha, Doha, Qatar.
Abstract

Breast cancer remains the most commonly identified malignant condition worldwide and represents the principal cause of death among women. To address this issue, population-based screening initiatives—primarily mammographic exams—began to appear in the 20th century. Their introduction has substantially lowered mortality and enhanced outcomes for individuals diagnosed with this illness. Even so, reading mammograms involves a certain level of inconsistency and depends heavily on the expertise and background of the clinicians who interpret them. Seeking to assist the assessment of mammographic images and strengthen the diagnostic workflow, this study introduces the conception, development, and proof of concept of an innovative intelligent clinical decision support system based on two predictive strategies executed in parallel. The first strategy uses several expert modules driven by fuzzy inference mechanisms designed to process the attributes linked to the chief mammographic findings. From this, a collection of indicators—termed Symbolic Risks—can be derived, each tied to the likelihood of breast cancer based on the detected features. The second strategy relies on a machine-learning classification model that, using both mammography-related descriptors and general patient data, computes another metric, called Statistical Risk, likewise associated with the probability of developing breast cancer. These metrics are then integrated to generate a combined measure, the Global Risk. This value may subsequently be adjusted using a weighting element derived from the BI-RADS category assigned by the medical specialists. The resulting Corrected Global Risk can then be interpreted to determine a patient’s status and issue tailored recommendations. The proof-of-concept evaluation and software implementation were performed using a dataset of 130 patients obtained from a database at the University of Wisconsin–Madison School of Medicine and Public Health. The initial outcomes were promising, suggesting the system’s potential utility, though thorough clinical testing in real practice settings is still required. Its integration into existing clinical information systems may further streamline diagnostic procedures and enhance patient outcomes.


How to cite this article
Vancouver
Al-Dosari M, Al-Marri F, Al-Sulaiti A. A Hybrid Fuzzy-ML Clinical Decision Support System for Breast Cancer Risk Stratification: Design, Symbolic/Statistical Risk Fusion, and Proof-of-Concept Validation. Asian J Curr Res Clin Cancer. 2024;4(2):106-22. https://doi.org/10.51847/Q2DsJjMLMM
APA
Al-Dosari, M., Al-Marri, F., & Al-Sulaiti, A. (2024). A Hybrid Fuzzy-ML Clinical Decision Support System for Breast Cancer Risk Stratification: Design, Symbolic/Statistical Risk Fusion, and Proof-of-Concept Validation. Asian Journal of Current Research in Clinical Cancer, 4(2), 106-122. https://doi.org/10.51847/Q2DsJjMLMM
Articles
Long-Term Survival Outcomes of Colorectal Cancer Survivors: An In-Depth Exploration
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Zhaobei Cai
Theoretical Model of Thiophene and Its Derivatives Interaction with BRCA-1
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Lauro FigueroaValverde
Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 1, 2022 | Lauro FigueroaValverde
Tolerability of Chemoradiotherapy in Geriatric Patients with Pancreatic Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | İrem Sarıcanbaz
Environmental Impact of the Y-Isomer of HCH: Unveiling Its Role in Cancer Formation
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 2, 2022 | Mata Uvaysovna Razhaeva
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.